BioScrip Cash Flow - Annual (NASDAQ:BIOS)

Add to My Stocks
$2.92 $0.01 (0.34%) BIOS stock closing price Jul 19, 2018 (Closing)

The BioScrip cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For BioScrip profits one has to check the income statement and for BioScrip debt one has to check the balance sheet. BioScrip cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents. BioScrip had cash and cash equivalents of $9.56M at the beginning of the year and $39.45M at year end for 2017. The cash from operating activities for BioScrip is $ 2017, which saw an increase from previous year.

View details of BioScrip cash flows for latest & last 10 financial years
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Net Income Cash Flow
-64.19M-41.5M-299.7M-147.46M-69.65M64.7M7.87M-69.14M54.09M-74.03M
Depreciation Depletion Amortization Cash-Flow34.72M25.59M26.18M27.09M22.48M13.73M16.93M14.14M5.03M100.27M
Net Increase (Decrease) in Assets Liabilities17.6M-11.43M-21.28M75.74M-32.43M38.19M-3.85M-26.98M-7.8M-31.22M
Cash From (used in) Discontinued Operations-5.5M-0.42M-6.17M-2.68M--96.02M----
Other Adjustments Net16.6M-14.99M236.24M15.89M25.05M6.27M6.02M60.56M-28.58M-3.76M
Net Cash from (used by) Operating Activities
-0.76M-42.76M-64.74M-31.41M-54.55M26.88M26.96M-21.41M22.74M-8.74M
Increase (Decrease) in Prop Plant And Equipment-8.68M-5.46M-11.54M-13.82M-25.62M-10.98M-9.44M-11.11M-5.73M-7.46M
Acquisition Disposition of Subsidiaires--67.51M--0.45M-282.99M-45.98M-0.46M-97.43M--
Increase (Decrease) in Investments----8.61M-----
Other Cash Inflow (Outflow) from Investment Activities-4.95M-24.56M57.68M-2.36M150.84M----
Net Cash from (used by) Investment Activities
-13.63M-72.98M13.02M44.25M-302.37M93.88M-9.9M-108.54M-5.73M-7.46M
Issuance (Purchase) of Equity Shares20.89M83.06M59.58M1.1M120.93M8.43M3M3.98M2.89M-0.42M
Issuance (Repayment) of Debt Securities79.66M-13.62M-0.39M21.93M134.89M-3.27M-2.63M89.96M--
Increase (Decrease) in Bank & Other Borrowings-55.3M40.3M10M-35M40M-63.82M-17.41M48.59M-20.02M16.63M
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-0.98M--2.63M-1.13M---0.02M-12.58M--
Net Cash from (used by) Financing Activities
44.28M109.74M66.55M-13.1M295.82M-58.66M-17.06M129.96M-17M16.2M
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
29.88M-6M14.83M-0.26M-61.1M62.1M----
Cash & Equivalents at Beginning of Year9.56M15.57M-1M62.1M-----
Cash & Equivalents at Year End39.45M9.56M15.57M-1M62.1M----
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

While BioScrip stock price history provides the price history of a stock, BioScrip stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • BioScrip had a Net Change in Cash and Cash Equivalents of $29.88M for the latest year 2017. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the BioScrip stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. BioScrip lost $-0.76M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash Flow from investment activities: BioScrip used $-13.63M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $44.28M for BioScrip. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For BioScrip Cash Flow